Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Liofilchem™ AD Fosfomycin
SDP

AD Fosfomycin is a 12-well panel containing the antibiotic incorporated into an agar medium in different concentrations. It is used to perform the AD method for the antimicrobial susceptibility testing of fosfomycin as recommended by CLSI and EUCAST standards.

$30.50 - $178.00

Specifications

Antimicrobial Agents Fosfomycin
Concentration 0.25 to 256 μg/mL
Product Type Panel
Sterility Non-sterile
Test Type Media Testing
View More Specs

Alert:

Non-hazardous according to current legislation but fall within the specific field of application where a safety data sheet must be supplied because they can cause phenomena of sensitisation in sensitive subjects if they come into contact with the skin.


Products 2
Catalog Number Mfr. No. No. per Pack Price Quantity & Availability  
Catalog Number Mfr. No. No. per Pack Price Quantity & Availability  
22-778-084
SDP
View Documents
Liofilchem™
77001
1 Ea.
Each for $30.50
Only null left
Add to Cart
 
22-778-085
SDP
View Documents
Liofilchem™
77061
6/Pk.
Each for $178.00
Only null left
Add to Cart
 
Description

Description

  • 1 panel of AD Fosfomycin 0.25-256
  • 2 Reading Templates (transparent and black backgrounds)
  • 1 Instructions Sheet also available at www.liofilchem.com/ifu-sds
Specifications

Specifications

Fosfomycin
Panel
Media Testing
0.25 to 256 μg/mL
Non-sterile
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.